FDA Inspection 883672 — Foulk & Whitten Nevada Center For Reproductive Medicine
The FDA completed an inspection of Foulk & Whitten Nevada Center For Reproductive Medicine on June 5, 2014 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 5, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Reno, NV (United States)